|
AU2003215384A1
|
|
Microdispersion treatment of a protein or pharmaceutical
|
|
WO02060475A1
|
|
Methods for stabilizing lyophilized blood proteins
|
|
US6693173B2
|
|
Method to remove citrate and aluminum from proteins
|
|
IL146433D0
|
|
A process for the preparation of an intravenously-administerable gamma globulin solution
|
|
AU3535000A
|
|
Purification of proteins
|
|
US6162904A
|
|
Manufacturing method for intraveneously administrable immune globulin and resultant product
|
|
US6441144B1
|
|
Method for repairing dual virally inactivated immune globulin for intravenous administration
|
|
IL131471D0
|
|
Production process for intravenous immune serum globulin and resultant product
|
|
AU7317398A
|
|
Alpha1-acid glycoprotein purification process and product
|
|
WO9830882A2
|
|
Method and system for testing blood samples
|
|
USH1960H
|
|
Automated method and system for testing blood samples
|
|
US6348336B1
|
|
Process for purification of PCR test samples
|
|
CA2252374A1
|
|
A process for viral inactivation of lyophilized blood proteins
|
|
US5780222A
|
|
Method of PCR testing of pooled blood samples
|
|
US5834660A
|
|
Method and system for testing blood samples
|
|
US5616693A
|
|
Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
|
|
US5744586A
|
|
Manufacturing process for the production of purified transferrin
|
|
AU5796196A
|
|
Method and system for testing blood samples
|
|
US5659017A
|
|
Anion exchange process for the purification of Factor VIII
|
|
US5591573A
|
|
Method and system for testing blood samples
|
